Eero Vasar is professor of physiology at the University of Tartu.
He has been visiting scientist in Institute of Psychiatry (London, 1989), University of Uppsala (1992) and University of Helsinki (1995). He is currently head of Institute of biomedicine and translational medicine, University of Tartu. Moreover, he is chairmen of the scientific board of the Centre of excellence for translational medicine (2008-2015).
Since 2010 he is a member of Estonian Academy of Sciences. He belongs to the evaluation committee of Estonian Research Council as expert in the field of health sciences and has served as evaluator for many granting agencies (U.K., France, Portugal, Finland, Bulgaria, FP7 and Horizon2020 of European Commission).
He has supervised or consulted 24 Ph.D. thesis. He has published more than 200 scientific papers dedicated to the different fields of basic and clinical research and his h-index is 36 (Scopus).
His major expertise is in the field of application of transgenic technology for study of basic mechanisms of neuropsychiatric disorders.
Mihkel Zilmer is a full professor of medial biochemistry at the University of Tartu.
His research focuses on translational medicine studies to integrate biochemical-metabolomical and functional-structural profiling (CVD, neurodegeneration, endothelium functionnality, arterial stiffness) and to investigate the role of oxidative stress in neurodegeneration, essential hyper-tension, CVD and concerning new antioxidative peptides, probiotics and functional food.
He has published more than 150 CC papers in several high-ranking medical journals (Eur Heart Journal, PLoS Genet, Int J Card, The Hypertension etc). He is an author of 10 patents (Estonia, Europe, USA, Japan, Russia etc). According to SCOPUS his papers has been cited more than 4600 times and his H-index is 37.
His team worked at the Centre of Excellence for Translational Medicine Centre and at the Competence Centre (the scientific-innovation centre between Universities and Enterprises) in 2005…2015. He is a member of the evaluation committee of Estonian Research Council as expert in the field of health sciences and has served as evaluator for several granting agencies (Estonian Science Foundation, SA Archimedes, etc).
He has supervised 26 PhD thesises. In 2009 he got the highest award of Estonian Republic in innovation and the highest quality-innovation award of Finland. In 1998 and 2013 he got the highest scientific award of Estonian Republic in the field of medicine.
At present his team is a member of the Centre of Excellence for Genomics and Translational Medicine. He is on of authors of evidence-based book “Novel Nutrition Recommendations of Estonia (2016)“. His areas of competence are medical and clinical biochemistry, athero-sclerosis and neurodegenerative aspects concerning metabolomics, endothelium, arterial stiff-ness, inflammation and oxidative stress, probiotics, molecular aspects of new antioxidants, science-based human nutrition and diseases, functional food.
Tambet Teesalu is professor of nanomedicine and head of the Laboratory of Cancer Biology of the University of Tartu.
He is an assistant professor at the Sanford-Burnham Medical Research Institute (SBMRI, La Jolla, USA). He earned his M.Sc. (1992, yeast molecular biology) and Ph.D. (1999, molecular developmental biology) in the University of Helsinki.
In 2005-2011 he worked as a senior researcher in the laboratory of Prof. Erkki Ruoslahti at the SBMRI. He has been awarded several prestigious fellowships including ERC starting grant, the Wellcome Trust international senior fellowship, EMBO installation grant, S. Komen for Cure Foundation career development grant.
His team is one of the leading laboratories in developing screening technologies to map “vascular ZIP codes” for targeted delivery of drugs and imaging agents to cancer and other diseases.
Pärt Peterson is professor of molecular immunology at the University of Tartu.
He graduated in molecular biology at the University of Tartu and defended his PhD on molecular immunology in 1996 at the University of Tampere, Finland. He spent his postdoctoral period in the Institute of Medical Technology where his research interest focused on the Autoimmune Regulator (AIRE) gene, the key factor in central thymic tolerance. He also co-discovered DNA methyltransferase 3-like (DNMT3L) gene, a regulator of DNA methylation and epigenetic imprinting He obtained the degree of Docent at the University of Tampere and in 2000 became a Fellow of the Finnish Academy, after which he has continued his research on AIRE and APECED syndrome.
In 2003-2009 he was supported by The Wellcome Trust as International Senior Fellow and started research group as Professor of Molecular Pathology at the University of Tartu, and in 2009 he was elected as the Research Professor of the Academy of Estonia.
Since 2008, he has worked as Professor of Molecular Immunology and is head of the Department of Biomedicine. He is chairman of the board of the Institute of Biomedicine and Translational Medicine. He has been a member of the Evaluation Committee of Estonian Research Council and has served as an evaluator for multiple grant agencies.
He is Editorial Board member of European Journal of Immunology, Scandinavian Journal of Immunology and Frontiers in Immunology. He has published over 130 research publications on various aspects of immunology and molecular biology, and his studies have been cited over 7400 times with H-index 47 (Scopus).
Allen Kaasik is professor of molecular toxicology at the University of Tartu.
He received his PhD(1998, pathophysiology) in the University of Tartu and made his postdoc at INSERM, France (1999-2000). Since then his research focuses on mechanisms of neuronal degeneration and protection. He is also active in experimental cardiology and has published several papers in leading journals of experimental cardiology (Circulation research, Cardiovascular Research).
He is the acting director of the Centre of Excellence for Translational Medicine, and from 2011, he is also the coordinating director of the Competence Centre of Disease Models and Biomedical Imaging.
He has been the coordinator of two EU framework program projects (BRAIN BIOENERGETICS, ESTBIOREG). He is member of the evaluation committee of Estonian Research Council as expert in the field of health sciences and has served as evaluator for many granting agencies (Estonian Sceince Foundation, SA Arhimedes, EL FP5, FP7, H2020 (SME, CIG, ITN, Marie Curie indicivual fellowships, mHealth, INTAS, Wellcome Trust, Health Research Board Ireland, French ANR, National University of Singapore, Fondazione Mariani).
He has published 55 scientific papers that has been cited over 5000 times and his H-index is 22 (Scopus). His major expertise is in the field of neurodegenerative disorders, neuropharmacology and toxicology.
Irja Lutsar MD, PhD is an internationally well known pediatric infectious disease specialist and the head of the department of Medical Microbiology at the University of Tartu.
She has extensive experience in designing, conducting and leading registration and academic clinical trials of all phases including trials in vulnerable populations such critically ill, immunocompromised and neonates.
She is heading the Estonian Network of pediatric Clinical trials (ELAV). She is the members or the pediatric Committee at European Medicines Agency and member of international consortia like PedCRin, PENTA etc. In 1999 to 2005 while working as a director at Pfizer Inc. she was leading clinical development of the voriconazole pediatric programme. She is and has been involved in several international programs like NeoVanc, Mon4STRAT, PedMermaids, Closed as work package leader.
She was a principle investigator in a recently completed pan-European randomised controlled trials NeoMero that recruited 272 infants with neonatal sepsi and 58 with neonatal meningitis. She is the member of evaluation committee of the Estonian Science Foundation, senat member of the University of Tartu and has been evaluator for the European Commission, National Institute of Health (USA), Medical Research Council (UK) and several other national agencies. She is the section head of the Pediatric Infectious Disease Journal, one of the top ranking journals in paediatrics.
Under her supervision 5 PhD students have defended their thesis and she is currently supervising 7 students. She has published 135 papers in peer-reviewed journal with more than 4000 citation and H-index 24 (Scopus).
Raivo Uibo is professor of immunology at the University of Tartu (since 1992) and a member of Estonian Academy of Sciences (since 2003).
He graduated Medical Faculty (MD) and performed candidate thesis (PhD, internal medicine) at the University of Tartu. His doctorate work was done at the University of Tampere (DMSc). He has been working for longer periods as visiting scientist at the University of Tampere, at the Centre of Molecular Biology and Medicine of the University of Monash, at the IRIBHN of the University of Brussels, at the Immunogenetic Laboratory of the University of Turku. In 2008 he has been working as visiting professor at the Clinical Research Center of the Lund University. In 2001-2007 he has been head and chairman of the council of Centre of excellence of molecular and clinical medicine (in 2003-2005 as EU NAS Centre of excellence), in 2008-2015 as a member of the scientific board of the Centre of excellence for translational medicine.
He has been as external evaluator for international and national granting agencies (EU FP and Horizon2020, in Finland, Ireland, Latvia, Spain, UK). In 2009-2015 he was a member of the Research Council in the Competence Centre of Reproductive Medicine and Biology and since 2004 in the Research Council in the National Institute for Health Development. He has been contractor or PI for international grants of EU FP (1996-2014, 5 projects), NIH Fogarty, Sigrid Juselius Foundation, European Foundation for the Study of Diabetes etc. Under his supervision 16 PhD thesis have been completed.
His publication list comprises over 200 scientific publications. His H-index is 31 (Scopus). His main research area is molecular and cellular mechanisms of autoimmunity, where his research group has recently concentrated to study immune mechanisms in diabetes and coeliac disease. His innovative efforts have been directed to study immune mechanisms in infertility and regeneration.
Aleksandr Žarkovski is full professor of pharmacology and drug toxicology at the University of Tartu.
He graduated in medicine at the University of Tartu and defended his PhD in psychopharmacolgy in 1978 at the University of Tartu, Estonia and defendent his habilitation Thesis (doctor of medical sciences) at the Institute of experimenta medicine St. Petersburg (Russia) in 1988. He had postodoctoral fellowships at the at the University of London (Welcome Trust fellowship) in 1989-1990, at the Karolinska institutet. Sweden (Laboratoty of Drug Addiction) 1990-1991 and Helsinki University (1991-1992).
In 1992 he was elected on the full rpofessor of pharmacology at the university of Tartu. His research interestes are focused on the mechanims of adaptation to psychotropic drugs treatment, mechanisms of drug addiction and mechanisms of regulation of brain plasticity.
He has contributed to the development and introduction into clinical practice three novel psychtropic drugs and created GLP certified toxiclogy laboratory.
Aleksandr Zarkovski was awarded an Estonian Government Research Awards in Medicine for the work "Nerve cell damage and drug addiction: molecular mechanisms and pharmacological prevention (2001) and for the work “Molecular mechanisms of brain plasticity” (2014).
He was a supervisor of 13 PhD students and cuurently under his supervision are 3 PhD students. Author and co-author of 140 publications. Over last five years he hes received several national and EU grants.
Maris Laan is professor of human genetics at the University of Tartu.
She received her PhD at the University of Helsinki (1997), followed by postdoctoral studies in Germany (LMU München, 1996-1998) and USA (MBL, Woods Hole, 1999-2000). Her research group was established with the support of Wellcome Trust International Senior Fellowship (2003-2012) and HHMI International Scholarship (2006-2011). The group has grown to a internationally recognized team in human cardiometabolic and reproductive genetics/genomics, and placental research.
She has coordinated the HAPPY PREGNANCY project (2012-2015), bringing together clinical and basic researchers in male and female reproductive biomedicine in Estonia. She has published close to 90 scientific articles with >4200 citations and her h-index is 31 (Google Scholar).
She has supervised 7 PhD thesis; currently 9 PhD students are under supervision. She has served as an expert for the Estonian Research Council and EC REA (FP7, H2020), as an evalutor for grant agencies in several European countries, in the Programme Organizing Committee for the European Congress in Endocrinology 2015 (ECE 2015, > 3000 participants).
In 2010, she received the Estonian National Science Award in Chemistry and Molecular Biology. In 2019, she becomes first female scientist to be awarded Baltic Academies of Sciences medal, which has been awarded since 1999.
Andres Salumets is the professor of reproductive medicine at Faculty of Medicine, and visiting professor at University of Helsinki.
He has published 105 publications (h-index 24).
Professor Salumets has had collaboration papers in Nature, Nature Genetics, Human Molecular Genetics, Genome Biology, Human Reproduction Update, Trends in Endocrinology and Metabolism.
He has supervised 7 PhDs and currently supervising 16 PhDs.
He is currently the member of the Executive Committee of European Society of Human Reproduction and Embryology and president of Baltic Fertility Society.
Alireza Fazeli holds a position of The ERA Chair for Translational Genomics and Personalized Medicine at the University of Tartu.
He studied Veterinary Medicine in Tehran University in Iran. In 1996 he obtained his PhD in Reproductive Biology from the Utrecht University, Netherlands.
His research interests focus on the periconception environment and its effect on the offspring epigenetic profile, maternal interactions with gametes and embryos as well as understanding the mechanisms involved in the mediation of the innate immune system in the female reproductive tract in health and disease.
He has published over 250 scientific communications, which 90 are scientific papers appeared in multidisciplinary peer reviewed journals. During his academic career he has trained over 60 PhD and MSc students and research associates. He has been main investigator or Co-PI for various EU-funded research projects with partners from more than 30 different European and European Associated countries.
He has been the chair and vice chairs of three pan-European Cost Actions. He has been a Trustee of the Infertility Research Trust, and a member of the Editorial Board for the journal Reproduction.
Vallo Tillmann is the professor of paediatrics at the University of Tartu.
He has been working as a Chief of Children’s Clinic and a Consultant in Paediatric Endocrinology at Tartu University Hospital since 2003. He is a practising physician looking after children with endocrine disorders. His main research interest has been diabetes, growth disorders and obesity.
During the last decade a biobank of study material (serum, blood cell samples, clinical data, etc.) from patients with diabetes has been established. In 2015 Vallo Tillmann was awarded an Estonian Government Research Award in Medicine for the work "Factors influencing the development of diabetes".
He has supervised 8 PhD theses and published 110 papers with more than 2000 citations and h-index 25 (Scopus).
Joel Starkopf is professor of anaesthesiology and intensive care at the University of Tartu, head of the Anaesthesiology and Intensive Care Clinic, Tartu University Hospital.
Since 2015 he has been the head of Institute of Clinical Medicine, Faculty of Medicine, University of Tartu. He has broad scientific experience from animal experiments to multicentre clinical trials and systematic reviews.
His research has focused on ischaemia-reperfusion of the heart and myocardial preconditioning; abdominal problems in intensive care patients; and pharmacokinetics of antibacterial drugs in severe sepsis and septic shock.
He has published 71 scientific papers and his h-index is 24 (Scopus).
He has substantial clinical experience as intensive care specialist, who is supervising the department of University Hospital responsible for highest level of anaesthesiology, intensive care and emergency medicine in Estonia.
Peep Talving is Professor of Surgery at the Department of Surgery, University of Tartu and the head of the Division of Acute Care Surgery at the North Estonia Medical Center (NEMC).
Previously, Dr. Talving was Assistant Professor of Surgery at the University of Southern California, Los Angeles, CA, USA.
Prof. Talving is a Board member of the Scandinavian Journal of Surgery and member of the Advisory Editorial Board of the European Journal of Trauma and Emergency Surgery. In addition, he is a reviewer of 13 surgical journals.
Prof. Talving’s research is focused on acute care surgery including emergency general surgery, trauma surgery and endovascular aortic interventions.
Prof. Talving is directing the Acute Care Surgery Research Group located in Tartu University Hospital and North Estonian Medical Centre, thus linking the facilities and the entire surgical population of Estonian tertiary referral hospitals.
Dr. Talving has published 151 original peer-reviewed scientific papers and his current h-index is 30 (Scopus).
Toomas Asser is professor of neurosurgery at the University of Tartu. From 1st of August 2018 he is the rector of University of Tartu.
He has sub-specialized in vascular neurosurgery in Sendai, Tohoku University, Japan with Professor Akira Ogawa (1989).
He has specific interest in neurovascular surgery, neuro-oncology, surgery of pituitary tumors, functional neurosurgery, and neuro-traumatology. His research interest has been cerebral hemodynamics and sequelae of aneurysmal subarachnoid haemorrhage; epidemiology of primary central nervous system tumors; molecular characteristics astrocytic gliomas, spinal cord injury, and deep brain stimulation in Parkinsons disease.
He has supervised 9 Ph.D. thesis. He has published 61 scientific papers and his h-index is 14 (Scopus). Since 2011 he is a member of Estonian Academy of Sciences.
He is the past (2011-2015) vicpresident of the European Association of Neurosurgical Societies (EANS) and currently president of the Baltic Neurosurgical Association (BNA).
Margus Lember is professor of propedeutics of internal medicine. He is the Head of the Department of Internal Medicine of the University of Tartu and University Hospital. Since January 1, 2016 he is the Dean of the Faculty of Medicine and member of the Rector`s Office.
He has received his PhD in internal medicine in Tartu 1990 and PhD in primary healt care at the University of Tampere, Finland in 1998.
His research interests cover diagnostics and epidemiology of chronic diseases (metabolic diseases, bone and joint diseases, functional gastrointestinal diseases), primary health care development and health services, medical education and quality of health care.
He has supervised 5 PhD thesis, currently supervising 7 PhD students. He has published 78 peer-reviewed international papers, his h-index is 15 (Scopus).
He is the president of the Estonian Society of Internal Medicine, has been an expert to the World Bank and WHO in several countries on development of healt care organization and medical education.
Jaan Eha is professor of cardiology at tehe University of Tartu, head of the Heart Clinic, Tartu University Hospital.
He is a practising physician looking after patients with different cardiac disorders. His main clinical speciality is interventional cardiology. His research has focused on treatment methods of chronic and acute myocardial ischemia, chronic heart failure and arterial hypertension. Preclinical changes of the endothelial function and biomarkers of early atherosclerosis are the areas of his research during the recent years.
He is a cofounder of Estonian Myocardial Infarction Registy and centre of endothelial research. He has more than 30 years experience in different positions of multicenter international clinical trials. He and his group have recieved several research grants from different financing institutions.
Prof. Eha has supervised 10 PhD theses. 4 PhD students are continuing their studies in 2017. In 1985 and 2013 Jaan Eha was awarded an Estonian Government Research Awards in Medicine for the works: 1. diagnostic methods and surgical treatment of stable coronary arter disease, 2. translational medical research in cardiovascular diseases.
He has been elected as honorary member of the Estonian Society of Cardiology (2007). Since 2016 he is a member of Estonian Academy of Sciences.
Külli Kingo is professor and head of the Department of Dermatology, University of Tartu and head of the Dermatology Clinic of the Clinics of Tartu University.
Since 2012, she has served as vice dean for Science in the Faculty of Medicine, University of Tartu. Külli Kingo is the Board Member of the European Academy of Dermatology and Venereology and representative of Estonia in the UEMS Section of Dermatology and Venereology.
Her research activities focus on defining the environmental and genetic determinants of inflammatory and pigmentary skin diseases such as psoriasis, atopic dermatitis and vitiligo. The goal of the Dermatology group led by Prof. Kingo is identification of novel diagnostic and prognostic markers and drug targets for better handling of chronic inflammation, including inflammatory skin diseases.
Prof. Kingo has been an investigator on over 20 phase II and III clinical trials in psoriasis and atopic dermatitis.
She has published 90 scientific papers and her h-index is 25 (Scopus). In 2016 Külli Kingo was awarded an Estonian Government Research Award in Medicine for the work "Pathogenesis of chronic inflammatory skin diseases".
Jaak Jürimäe is a professor of coaching sciences at the Institute of Sport Sciences and Physiotherapy, University of Tartu.
He earned his PhD in exercise physiology in 1996 at the University of Queensland, Australia. His research has been emphasized on monitoring training stress, and finding new markers of fatigue and overtraining in athletes. Another research area focuses on physical activity, physical fitness and body composition in children during growth and maturation.
Jaak Jürimäe was a national representative of the Active Healthy Kids Global Alliance that recently assessed physical activity of children in 38 countries from all over the world.
He is a board member of the European Group of Paediatric Work Physiology and member of the European College of Sport Sciences Reviewing Panel. Dr. Jürimäe is a co-author of two monographs (CRC Press, Karger).
He has published more than 190 papers and chapters in the peer-reviewed journals and books. His work has been cited more than 3000 times and his h-index is 32 (Scopus).
Jaak Jürimäe has supervised 13 PhD theses.
Jarek Mäestu is an assistant professor of sport biology in Institute of Exercises and Sport Sciences.
Since 2016 he has worked as a vice dean of development in the Faculty of Medicine. He defended his PhD in 2004 and his research areas cover training related adaptation, coaching sciences and physical activity and health in children and adolescents.
He has published over 100 scientific papers and his H-index is 18 (ISI-WoS). He has supervised 5 PhD thesis.
He is in streering committee of Estonian Children Behavioral, Personality and Health study, a prospective longitudinal population based multidisciplinary study that started in 1998. He is a member on Disciplinary Commitee of Estonian Antidoping and belonged to the team who worked on Estonian “Green book of nutrition and physical activity”.
Jyrki Heinämäki is a full-time Professor of Pharmaceutical nanotechnology in the Insitute of Pharmacy. Dr. Heinämäki obtained his PhD at the University of Helsinki, Finland in 1991 and was appointed as a Docent in Pharmaceutical technology at the University of Helsinki in 1995. In 2010, he was appointed as a full Professor in Medical technology for 5 years at the University of Tartu. He has been also an invited professor (a permanent honorary professorship) at the University of Havana, Cuba since 2008.
Over the last two decades, his expertize has been mainly focused at the fields of materials and process research of oral pharmaceutical solid dosage forms, especially in the fields of powder technology, granulation, pelletisation, tableting, film coating and surface engineering of pharmaceutical solids.
He is also specialized in controlled drug release and more recently in nanofibrous drug delivery systems. To date, Dr. Heinämäki has authored or co-authored 105 original peer-reviewed scientific articles in international journals and over 20 articles (extended abstracts) in conference proceedings.
Currently, his h-index is 26 (Scopus). He has also successfully supervised or co-supervised total 16 PhD theses in the abovementioned research fields.
Anneli Uusküla is a professor of epidemiology at the Department of Family medicine and public health, and serves as dermatovenerologist at the Clinic of Dermatology of the University of Tartu.
Uusküla has domestic research experience in HIV and a demonstrated track record of international research collaboration. With domestic funding and international research support A. Uusküla has been able to explore determinants and behavioural patterns associated with the sexually transmitted infections/HIV/injection drug use epidemics at multiple levels (community, individual) using different sampling methodologies (convenience sampling, population based sampling, respondent driven sampling), and to tests for disease prevention opportunities using randomized controlled study design.
She has published over 90 peer reviewed publications, and her h-index is 19 (Scopus).
Dr. Uusküla is a recipient of the National institutes for health (NIH) USA R01 grants and several research grants from U.S. Civilian Research & Development Foundation (CRDF). Uusküla is experienced in EU projects, he has been a partner in several EU FP6, FP7 projects.
Ruth Kalda is professor of family medicine at the University of Tartu.
She is head of the Institute of Family Medicine and Public Health. She has broad scientific experience in primary care studies such as quality related issues, doctor-patient relationship and chronically ill patient's empowerment, continuity of the care and the care integration.
She has experience also in qualitative research. She has published 46 scientific papers in peer-reviewed international journals and more than 20 in the journal "Estonian Physician".
Her h-index is 13 (Scopus). She has long-term clinical experience in family medicine, working also as a family physician.
She belongs to the various Committees and Councils in Estonia and internationally, such as: Council of the Medical Faculty, University of Tartu, Residency Training Committee, Committee of the Final Exam of the Undergraduate Studies of the Medical Faculty, Committee of the Doctoral Studies of the Medical Faculty, Scientific editor of the journal "Estonian Physician", Council of the Clinical Guidelines, Member of the Board of the Estonian Society of the Family Doctors, Estonian representative in the Council of Wonca Europe (World Organisation of the Family Doctors), Council member and Executive Board member of the EURACT (European Academy of the Teachers in Family Medicine), member of the Research Ethics Committee at the University of Tartu, member of the International Advisory Board of the British Journal of General Practice.